Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Oct 21, 2008; 14(39): 6065-6071
Published online Oct 21, 2008. doi: 10.3748/wjg.14.6065
Published online Oct 21, 2008. doi: 10.3748/wjg.14.6065
Table 4 CYP3A based clinical significant drug interactions with clarithromycin
Concurrent medications primarily metabolized by CYP3A | Clarithromycin | References | |
SR | IR | ||
Alprazolam and zolpidem | 1 | [6,7] | |
Midazolam | 1 | [6,8] | |
Amlodipine | 1 | 2 | [9] |
Levoamlodipine | 1 | ||
Nifedipine | 1 | [10] | |
Carbamazepine | 1 | [11] | |
Nifedipine, clopidogrel and atorvastatin | 1 | [10,12-14] | |
Amlodipine and ergoloid mesylate sustained release capsules | 1 | [9,15] | |
Prednisone | 1 | [16] |
- Citation: Zhou Q, Zhu LL, Yan XF, Pan WS, Zeng S. Drug utilization of clarithromycin for gastrointestinal disease treatment. World J Gastroenterol 2008; 14(39): 6065-6071
- URL: https://www.wjgnet.com/1007-9327/full/v14/i39/6065.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.6065